MIRM•benzinga•
JMP Securities Maintains Market Outperform on Mirum Pharmaceuticals, Raises Price Target to $76
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 9, 2025 by benzinga